Search | Médecins Sans Frontières Access Campaign

9 results found

Statement |

16 January 2013

MSF addresses study by Massachusetts General Hospital on implications of switching from branded to generic antiretrovirals for HIV

Tags HIV/AIDS HIV/AIDS antiretroviral medicinesFDCs PEPFARWorld Health AssemblyGilead

Opinion article |

05 January 2012

ICASA conference: donor retreat and its consequences for patients and communities

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines ICASAPEPFAR

Thenjiwe Madzinga, 66, sits on with her grandson Thina Gxotelwa in the small room they share in a shack in Cape Town's Khayelitsha township, February 23, 2010. Madzinga cares for her five grandchildren, including four who were orphaned when Madzinga's own daughter died from AIDS in 2002. Some 5.5 million people live with HIV/AIDS in South Africa - more than in any other country - placing a heavy burden on a society still struggling with the legacy of Apartheid.

Press release |

27 May 2010

Donor Retreat Widens HIV/AIDS Treatment Gap in Africa

Tags HIV/AIDS HIV/AIDS antiretroviral medicines PEPFARUNITAID

Press release |

09 March 2010

AIDS Care Gap between Europe and Southern Countries Risks Becoming a Chasm

Tags HIV/AIDS HIV/AIDS antiretroviral medicinesstavudine universal access PEPFARWorld Health Organization

Report |

05 November 2009

Punishing Success? Early Signs of a Retreat from Commitment to HIV/AIDS Care and Treatment

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines PEPFAR

Research article |

18 May 2009

Rationing Antiretroviral Therapy in Africa - Treating Too Few, Too Late

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines PEPFARWorld Health Organization

Press release |

27 January 2005

MSF: global AIDS treatment efforts not on track

Tags HIV/AIDSIntellectual property and tradeResearch and development HIV/AIDS antiretroviral medicines diagnostic tests PEPFARUNAIDSWorld Health Organization

Press release |

18 May 2004

MSF statement on US government announcement of new procedure for reviewing the safety and efficacy of fixed-dose combinations and co-blisters of antiretrovirals

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicinesFDCs PEPFARWorld Health Organization

Press release |

30 January 2003

MSF Welcomes President Bush’s Commitment to Scale-Up Access to Affordable AIDS Treatment, But Warns US Against Breaking Promises, Taking a Unilateral Approach

Tags HIV/AIDS HIV/AIDS antiretroviral medicines PEPFAR

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

MSF addresses study by Massachusetts General Hospital on implications of switching from branded to generic antiretrovirals for HIV

ICASA conference: donor retreat and its consequences for patients and communities

Donor Retreat Widens HIV/AIDS Treatment Gap in Africa

AIDS Care Gap between Europe and Southern Countries Risks Becoming a Chasm

Punishing Success? Early Signs of a Retreat from Commitment to HIV/AIDS Care and Treatment

Rationing Antiretroviral Therapy in Africa - Treating Too Few, Too Late

MSF: global AIDS treatment efforts not on track

MSF statement on US government announcement of new procedure for reviewing the safety and efficacy of fixed-dose combinations and co-blisters of antiretrovirals

MSF Welcomes President Bush’s Commitment to Scale-Up Access to Affordable AIDS Treatment, But Warns US Against Breaking Promises, Taking a Unilateral Approach